Regen BioPharma Inc (RGBP) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2025)
- $236.6K
- Net Income/Loss (FY2025)
- -$1.3M
- Total Assets (FY2025)
- $274.6K
- Total Equity (FY2025)
- -$6.3M
- Cash Flows from Operating Activities (FY2025)
- -$383.6K
Source: Regen BioPharma Inc 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
